Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely methenamine mandelate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methenamine mandelate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methenamine mandelate 0.5 gram/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methenamine mandelate and sodium phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methenamine mandelate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methenamine mandelate 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
Has basis of strength substance (attribute) |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methenamine mandelate 500 mg oral tablet |
Has precise active ingredient |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
Has precise active ingredient |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methenamine mandelate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
Has precise active ingredient |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methenamine mandelate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |